Background: Pentavalent antimonials remain as the standard drugs in the treatment of cutaneous leishmaniosis. The high cost, difficult administration, long treatment time, toxicity and increasing morbidity are factors that limit the use of these drugs. oBjectives: To describe the response to radiofrequency thermotherapy in the treatment of localized cutaneous leishmaniasis in Brazil, and to evaluate its safety and tolerability. Methods: We conducted a non-comparative open trial with a total of 15 patients confirmed to have cutaneous leishmaniasis on parasitological examination. A single radiofrequency thermotherapy session at 50ºC for 30 seconds was applied to the lesion and its edges. In patients with more than one lesion, only the largest one was treated initially. If after 30 days there was no evidence of healing, the smaller lesion was also treated with thermotherapy. Clinical cure was defined as visible healing for three months after treatment. The patients were followed-up for six months and there was no follow-up loss. results: Of all 23 lesions, only two evolved to complete healing without the need of treatment. Of 21 lesions, 18 (85.7%) achieved full healing. The main observed side effects were itching, burning sensation, pain and blisters. study liMitations: Sample with a small number of patients and short follow-up. conclusion: Thermotherapy can be considered a therapeutic alternative in localized cutaneous leishmaniasis, especially in cases of single cutaneous lesions and with formal contraindications to conventional treatment with pentavalent antimonials.
INTRODUCTION
Cutaneous leishmaniasis (CL) is an infectious disease caused by protozoa of the genus Leishmania, transmitted to men and other mammals through the bite of phlebotomine sandflies.
The disease is endemic in more than 70 countries, with 90% of cases occurring in Afghanistan, Algeria, Brazil, Pakistan, Peru, Saudi
Arabia and Syria. In the New World, it is found from the south of the United States to the north of Argentina. The annual incidence is estimated in 1-1.5 million cases. 1, 2 In Brazil, it is present in all states, with an increased incidence over the last 20 years, with a mean of 25,000 new cases/year and 8 to 18 cases/100,000 inhabitants. The North region contributes with the larger number of cases (around 40% of the total of registered cases) and has the highest mean coefficients (73.3 cases/100,000 inhabit.), followed by the Mid-West (35.4 cases/100,000 inhabit.) and Northeast (18.8 cases/100,000 inhabit.)
regions. 3 Although the state of Piauí, located in the Northeast of Brazil, is one of the states with the highest number of visceral leishmaniasis, its incidence of CL remains low, occupying the 4 th place among the states of the Northeast. In 2014, the state of Piauí notified 85 cases of American tegumentary leishmaniasis, with a coefficient of detection of 4.1 cases per 100,000 inhabitants. 4 Leishmaniases are among the most neglected diseases due to the limited resources invested in its diagnosis, treatment and control, together with its strong association to poverty and social conflicts. They occur more frequently in economically unfavored areas, without basic sanitation, low educational and income levels. 5 They represent one of the dermatological conditions that most deserve attention due to their magnitude, by the risk of causing deformities in humans and also by the psychological involvement, that is reflected in the social and economic fields. Clinical manifestations of ATL are diverse, depending on the Leishmania species involved and host factors, including their immune response. It is also possible that these factors have a role in the persistence of the parasite. 8 Clinically, ATL can present basically in 4 forms: localized CL, mucocutaneous leishmaniasis, disseminated CL and diffuse CL. The initial manifestation of the disease is characterized by an erythematous papule or nodule, usually on an exposed area of the skin, that progresses to a well-defined ulcer with rolled edges and coarse granulations in the center, covered by a serous-bloody exudate or not. They are usually found on exposed areas like the face, arms and legs. 9 The involvement of nasal mu- 39 A recent study performed in India with 100 patients randomized into two groups showed an elevated efficacy of both the radiofrequency thermotherapy and the intralesional antimonial after 12 weeks follow-up. 40 The efficacy and safety of miltefosine was compared to thermotherapy in a randomized controlled trial with 294 CL patients by L. panamensis and L. braziliensis performed in Colombia.
There was no statistically significant difference between both treatments, which demonstrated a cure rate around 70%. There was also no statistically significant difference in the response to treatment regarding the causative species of the disease. However, the number of side effects reported with miltefosine was higher. 41 In Brazil, a study performed in Bahia compared the systemic inflammatory response through the dosage of inflammatory cytokines after radiofrequency thermotherapy and after conventional treatment with pentavalent antimonial and demonstrated that, in both, there was an elevation in the inflammatory cytokines, with no statistically significant difference. However, it is not known if this change in the inflammatory response is a direct result of thermotherapy and the systemic medication or if it results from the healing process triggered by the treatments performed. It was also noted that in a patient with only one of two lesions treated with radiofrequency thermotherapy, the untreated lesion progressed to healing. The mean age of the patients was 43 years, with a minimum of 16 years and maximum of 79 years, being 60% of patients male.
More than half of the patients had only one lesion, and only one patient had three lesions. None of the patients had a previous history of leishmaniasis, however, five patients reported that some family member already had the disease. Secondary infection was seen before the treatment in five patients and was adequately treated with oral cephalexin before the treatment. The parasitological diagnosis was confirmed in 60% of patients with the presence of amastigotes.
The remaining patients had a histology suggestive of CL. Among the changes found, the most common were chronic granulomatous dermatitis with pseudoepitheliomatous hyperplasia in the epidermis and lymphoplasmacytic inflammatory infiltrate. Montenegro test was performed in all patients, and the two-digit mean of the test result was of 10.7mm. Culture was positive for Leishmania sp in only two (25%) out of eight patients in which this exam was performed.
All patients included in the study had a conventional PCR positive to Leishmania sp.
A total of 23 lesions was evaluated and of those, most were ulcers (56.52%), followed by plaques (21.74%), papules (13.04%) and nodules (8.7%). Regarding the site of the lesions, the majority was located on the lower limbs (60.87%), 30.43%, on the upper limbs and 8.7%, on the head. The mean duration of the lesions reported by the patients was around three months ( Table 2 ).
All patients returned for follow-up and there was no loss to follow-up. Complete cure in three months after the treatment was seen in 13 patients (86.67% CI 95% 54.63% to 97.23%) ( Table 3 ). The mean cure time of the 13 patients considered to be cured was of two months. None of the patients who had complete healing of the lesions had recurrence of the lesions in 12 months of follow-up.
Of the seven patients with more than one lesion, only two had healing of the untreated lesions ( Figure 1 ). Five needed radiofrequency thermotherapy for the remaining lesions and not only on the larger lesion. This happened because, after 30 days of the initial treatment, the adjacent lesions did not show signs of progression to healing and some of them even increased in size.
One patient did not achieve cure after three months of follow-up and refused systemic therapy with meglumine antimoniate but evolved with a good response and complete healing of her two lesions three months after another session of radiofrequency thermotherapy ( Figure 2) . The other patient considered as a therapeutic failure had a 75% reduction in his ulcer but did not show a complete reepithelialization of the skin to considered completely cured. This patient was treated with meglumine antimoniate.
Of the total of 23 lesions, only 15 were treated initially (one from each patient). After 30 days, the lesions were reassessed and only two (25%) of the eight untreated lesions did not progress to cure without the need of thermotherapy. Thus, of the 21 lesions treated, 18 progressed to cure after the treatment (85.7% CI 95% 63.7% to 97.0%) ( Table 4) . Two were excluded from the analysis because they were not treated.
The main side effects reported by the patients were pain found a mean efficacy of 73.2%, inferior to the one in this study. 45 The highest cure rates ever described with this treatment modality were in India (98%), in a study conducted to compare the efficacy of thermotherapy and intralesional antimonial (94%) in patients with L. tropica lesions. 40 One study performed at a military hospital in Washington, with soldier that acquired the disease by L.major in Iraq or Kuwait, showed one of the lower cure rates (48%) among the studies published. 39 It is possible that factors such as the host immunological response and their nutritional status, as well as differences between the species causative of the disease are responsible for the discrepancy between the cure rates found in the studies. Although in our study the Leishmania species causative of the disease was not identified, it is likely that the lesions have been caused by L. braziliensis in the majority of patients. 3 A study performed previously in Guatemala with 66 patients to assess the efficacy of thermotherapy demonstrated an efficacy of 73% in patients with CL by L. braziliensis and L. mexicana, the same as patients treated with systemic pentavalent antimonial. 34 In other two randomized studies that also compared thermotherapy with systemic pentavalent antimonial performed in Colombia, the cure rate was lower, around 60%. In these studies, the species responsible for the infection were L. panamensis, L. braziliensis and L. guyanensis. 35, 36 If we compare the results of these studies with other Most studies demonstrated that one single application of local heat by the radiofrequency device is enough to promote a complete reepithelialization of the lesions and achieve cure. Only in two studies thermotherapy was performed in more than one session.
In one of them, performed in Guatemala, the regimen was of three weekly applications of thermotherapy with a cure rate of 73%, and in the other performed in Iran, the authors opted to use the therapy once a week for four weeks, with an efficacy of 81%. 34, 38 A higher thermal dose with more applications or a higher temperature might improve the cure rates without increasing the side effects. However, in our study, we opted for the application of a single session of the therapy with good results.
The only study performed in Brazil with this device had the objective to determine if the healing of the CL lesions caused by therapy with local heat was associated to the modulation of the systemic response by inflammatory cytokines compared to conventional therapy with meglumine antimoniate. 42 The evaluation of efficacy was impaired in this study since the patients who did not respond received the recommended treatment with pentavalent antimonial 28 days after the application of local heat. Thus, our study is groundbreaking in Brazil in regards to the evaluation of the efficacy of this alternative therapy to CL.
There is a lack of controlled studies with patients with mul- confirmed by this study was described in a previous report. 30 The mechanism for this distance cure effect is not known. Possibly, the inflammatory response generated on the site where the heat was applied induces a systemic immune response with an effect inducing distant healing.
The patients that did not progress with proper healing three months after the treatment were considered a therapeutic failure. patients already treated with thermotherapy, there was no evidence of mucosal leishmaniasis after 12 months of follow-up. 34 Moreover, in India, a long-term efficacy study did not show parasites in the skin through PCR even after 18 months of follow-up. 40 Along the years, the therapy with pentavalent antimonial has been used as the drug of choice for the treatment of CL. However, due to its toxicity, need for laboratory tests for monitoring, difficult administration, long time for treatment, poor adherence, cost and reduced efficacy over time attributable to incomplete administration of therapeutic regimens, their use should be restricted to those situations where systemic treatment is strictly necessary.
Among these situations are cases of disseminated mucosal leishmaniasis, diffuse leishmaniasis and sites where heat therapy should be avoided, such as areas close to mucous membranes. Thus, most patients with few lesions of localized CL would be spared from a treatment more aggressive than the disease itself. This benefit would be especially important for elderly patients. Many times, this group of patients receive a toxic systemic treatment because of an ulcerated lesion that was not even confirmed to be CL with the parasitological methods. This would avoid fatal outcomes such as the ones previously reported. 17, 18 One of the main ways found to lessen the disadvantages of the use of systemic pentavalent antimonial is using it intralesionally.
With this, most of the side effects are minimized. The efficacy of intralesional antimonial was already registered and it ranges from 80-92%. 40, 49 However, studies published in Iran show a not so high cure rate for this treatment modality, with an efficacy between 40-60%. 38, 50 Other disadvantages include the need for multiple applications, reducing patient adherence, a larger amount of side effects when compared to thermotherapy, the cost and the need for laboratory monitoring.
New therapeutic options have been sought. However, despite good results, none of them was considered convenient or sufficiently effective to replace conventional treatment. Among the localized treatment options, radiofrequency thermotherapy appears as a viable option, since it is effective and requires only one session, improving patient adherence. One of the main advantages of this therapy is that the device is easy to use, light and works with rechargeable batteries, making it possible to be used in rural areas or areas with no electricity. Another advantage of this treatment modality is that it does not require monitoring with laboratory tests, saving additional costs for health institutions. Although the thermotherapy device is still relatively expensive, making it of difficult access in endemic countries, the costs related to conventional treatment are higher. Another possibility to be investigated is the association of thermotherapy to new oral treatment options, such as miltefosine, for example. All these advantages make this therapy a good alternative for the treatment of localized CL, particularly in patients who have absolute or relative contraindications to the conventional therapy, such as heart, kidney and liver conditions, pregnant women and HIV-positive patients.
CONCLUSIONS
Taking the results of this study into consideration, we conclude that radiofrequency thermotherapy can be considered as a possible alternative to pentavalent antimonials for the treatment of localized CL in Brazil, especially in cases of a single lesion and when there is formal contraindication to conventional treatment.
Additional randomized controlled studies are needed and are being conducted with a larger number of patients and a longer follow-up period, so that this treatment modality be considered as one of the main alternatives to conventional treatment for localized CL in Brazil. q
